
For further information please contact:
Dr. Petra Henrich-Noack
phone +49(391)6263794 or 6117204
noack@ifn-magdeburg.de

Recent publications:
P. Henrich-Noack, J.H.M. Prehn, J. Krieglstein
TGF-ß 1 protects hippocampal neurons against degeneration caused by
transient global ischemia - dose response relationship and potential
neuroprotective mechanisms, Stroke 27 (1996): 1609-1615
Block, F., Tondar, A., Schmidt, W., Schwarz, M.:
Delayed treatment with rolpram protects against neuronal damage following global ischemia
in rats. NeuroReport 8, 3829 - 3832 (1997)
Henrich-Noack, P., Hatton, C. D: and
Reymann, K.G.: The mGlu receptor ligand (S)4C3HPG protects neurons
after global ischemia in gerbils. Neuroreport, 1998, 9, 985-988
Dirnagl U, Thoren P, Villringer A, Sixt
G, Them A, Einhäupl KK: Global forebrain ischaemia in the rat: controlled
reduction of cerebral blood flow by hypobaric hypotension and two-vessel
occlussion. Neurological Res. 1993;15:128-30
C. Rauca, P. Henrich-Noack, K. Schäfer, V. Höllt, K.G. Reymann
(S)-4C3HPG reduces infarct size after focal cerebral ischemia;
Neuropharmacology 37 (1998): 1649-1652
P. Henrich-Noack, P.J. Flor, C.
Sabelhaus, K. Prass, U. Dirnagl, F. Gasparini, A. Sauter, M. Rudin, K.G.
Reymann: Distinct influence of group III metabotropic glutamate receptor
agonist (R,S)-PPG on different forms of neurodegeneration;
Neuropharmacology 39 (2000): 911-927
Gill, R., Nordholm, L., Lodge D.: The
neuroprotective action of 2,3-dihydroxy-6-nitro- 7-sulfamoyl-benzo(F)
quinoxaline (NBQX) in a rat focal ischemia model. Brain Res. 580, 35-43,
1992.Gill R.: (AMPA)/kainite antagonists and their role in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 6, 225-256, 1994.
Green, P.S., Simpkins, J.W.:
Neuroprotective effects of estrogens: potential mechanisms of action. Int.
J. Dev. Neuroscience 18, 347-358, 2000.